☆ 4.7 Article

Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

GENES & DISEASES (2023)

Related references

Note: Only part of the references are listed.
Article Food Science & Technology

Testing in vitro tools for the prediction of cholestatic liver injury induced by non-pharmaceutical chemicals

Eva Gijbels et al.

Summary: The study aimed to test the applicability of tools for predicting drug-induced liver injury on non-pharmaceutical compounds with cholestatic potential. The results showed cholestatic liability of sunset yellow, tartrazine, and triclosan, with tartrazine inducing transcriptional changes resembling those of cholestatic drugs. Additionally, unique gene modulation by tartrazine may serve as potential novel biomarkers for chemical-induced cholestatic liver injury.

FOOD AND CHEMICAL TOXICOLOGY (2021)

Add to Collection
Article Toxicology

Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Eva Gijbels et al.

ARCHIVES OF TOXICOLOGY (2020)

Add to Collection
Article Toxicology

Development of an Adverse Outcome Pathway From Drug-Mediated Bile Salt Export Pump Inhibition to Cholestatic Liver Injury

Mathieu Vinken et al.

TOXICOLOGICAL SCIENCES (2013)

Add to Collection
Article Gastroenterology & Hepatology

Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis

Kumi Kitamura et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)

Add to Collection
Review Pharmacology & Pharmacy

Rho GTPases as therapeutic targets for the treatment of inflammatory diseases

DZ Zhao et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2003)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.